These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33103107)

  • 1. Protein-driven mechanism of multiorgan damage in COVID-19.
    Estrada E
    Med Drug Discov; 2020 Oct; ():100069. PubMed ID: 33103107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions.
    Estrada E
    Viruses; 2021 May; 13(5):. PubMed ID: 34066091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation.
    Fu L; Gilham D; Stotz SC; Sarsons CD; Rakai BD; Tsujikawa LM; Wasiak S; Johansson JO; Sweeney M; Wong NCW; Kulikowski E
    Int Immunopharmacol; 2023 Apr; 117():109929. PubMed ID: 36857935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
    Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
    Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2.
    Chen X; Li H; Song H; Wang J; Zhang X; Han P; Wang X
    J Extracell Vesicles; 2022 Dec; 11(12):e12288. PubMed ID: 36450704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients.
    Sun R; Cai Y; Zhou Y; Bai G; Zhu A; Kong P; Sun J; Li Y; Liu Y; Liao W; Liu J; Cui N; Xiang J; Li B; Zhao J; Wu D; Ran P
    Front Immunol; 2023; 14():1052141. PubMed ID: 37251406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.
    Sur S; Steele R; Isbell TS; Ray R; Ray RB
    mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage.
    Deinhardt-Emmer S; Wittschieber D; Sanft J; Kleemann S; Elschner S; Haupt KF; Vau V; Häring C; Rödel J; Henke A; Ehrhardt C; Bauer M; Philipp M; Gaßler N; Nietzsche S; Löffler B; Mall G
    Elife; 2021 Mar; 10():. PubMed ID: 33781385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.
    Kumar S; Zhi K; Mukherji A; Gerth K
    Viruses; 2020 Apr; 12(5):. PubMed ID: 32357553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
    Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
    EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19.
    Motallebnezhad M; Omraninava M; Esmaeili Gouvarchin Ghaleh H; Jonaidi-Jafari N; Hazrati A; Malekpour K; Bagheri Y; Izadi M; Ahmadi M
    Pathol Res Pract; 2023 Jan; 241():154280. PubMed ID: 36580795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage.
    Kirtipal N; Kumar S; Dubey SK; Dwivedi VD; Gireesh Babu K; Malý P; Bharadwaj S
    Infect Genet Evol; 2022 Apr; 99():105254. PubMed ID: 35217145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics.
    Singh SP; Bhatnagar A; Singh SK; Patra SK; Kanwar N; Kanwal A; Amar S; Manna R
    Mini Rev Med Chem; 2022; 22(16):2102-2123. PubMed ID: 35105287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 cellular tropism and direct multiorgan failure in COVID-19 patients: Bioinformatic predictions, experimental observations, and open questions.
    Valyaeva AA; Zharikova AA; Sheval EV
    Cell Biol Int; 2023 Feb; 47(2):308-326. PubMed ID: 36229927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine storms after severe infections.
    Wang Y; Liu S; Li L; Li L; Zhou X; Wan M; Lou P; Zhao M; Lv K; Yuan Y; Chen Y; Lu Y; Cheng J; Liu J
    J Control Release; 2022 Sep; 349():118-132. PubMed ID: 35792186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.
    Estrada E
    Chaos; 2020 Aug; 30(8):081104. PubMed ID: 32872802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-specific or personalized treatment for COVID-19: rationale, evidence, and potential candidates.
    Mousavi SZ; Rahmanian M; Sami A
    Funct Integr Genomics; 2022 Jun; 22(3):429-433. PubMed ID: 35290538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.